1. Home
  2. Detail

@saly_luoi: test #jingliuhonkaistarrail #cosplayer #fyp #viral #xuhuongtiktok

Trĩ 3 cục r
Trĩ 3 cục r
Open In TikTok:
Region: VN
Sunday 12 July 2026 23:04:51 GMT
682
142
5
2

Music

Download

No Watermark .mp4 (1.99MB) No Watermark(HD) .mp4 (1.07MB) Watermark .mp4 (2.22MB) Music .mp3

Comments

brunnnnnn234
Chim chích bông của bún :
🥰🥰🥰
2026-07-13 02:53:39
0
user6vdk28aoz9
An Trịnh :
😳
2026-07-12 23:37:04
0
To see more videos from user @saly_luoi, please go to the Tikwm homepage.

Other Videos

So cool… ☠️
So cool… ☠️
@Fernandinho Torres o que acharam?? #fernandinhotorrescy #brasil #rolex
@Fernandinho Torres o que acharam?? #fernandinhotorrescy #brasil #rolex
Cái chân ẻm điệu dữ chưa☺️😍😍#Dopypet #spathucung #xuhuong #fyp #groomingdog
Cái chân ẻm điệu dữ chưa☺️😍😍#Dopypet #spathucung #xuhuong #fyp #groomingdog
Expand for Serious Side Effects incl. potential for blood to clot, and see profile for the HEMLIBRA full Prescribing Information and Medication Guide. Intended for US audiences only. ------ What is HEMLIBRA? HEMLIBRA is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A with or without factor VIII inhibitors. ------ What is the most important information I should know about HEMLIBRA? HEMLIBRA increases the potential for your blood to clot. People who use activated prothrombin complex concentrate (aPCC; Feiba®) to treat breakthrough bleeds while taking HEMLIBRA may be at risk of serious side effects related to blood clots. -- These serious side effects include: • Thrombotic microangiopathy (TMA), a condition involving blood clots and injury to small blood vessels that may cause harm to your kidneys, brain, and other organs • Blood clots (thrombotic events), which may form in blood vessels in your arm, leg, lung, or head -- Carefully follow your healthcare provider’s instructions regarding when to use an on-demand bypassing agent or factor VIII, and the dose and schedule to use for breakthrough bleed treatment. If aPCC (Feiba®) is needed, talk to your healthcare provider in case you feel you need more than 100 U/kg of aPCC (Feiba®) total. -- Your body may make antibodies against HEMLIBRA, which may stop HEMLIBRA from working properly. Contact your healthcare provider immediately if you notice that HEMLIBRA has stopped working for you (eg, increase in bleeds). -- The most common side effects of HEMLIBRA include: injection site reactions (redness, tenderness, warmth, or itching at the site of injection), headache, and joint pain. These are not all of the possible side effects of HEMLIBRA. You can speak with your healthcare provider for more information.
Expand for Serious Side Effects incl. potential for blood to clot, and see profile for the HEMLIBRA full Prescribing Information and Medication Guide. Intended for US audiences only. ------ What is HEMLIBRA? HEMLIBRA is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A with or without factor VIII inhibitors. ------ What is the most important information I should know about HEMLIBRA? HEMLIBRA increases the potential for your blood to clot. People who use activated prothrombin complex concentrate (aPCC; Feiba®) to treat breakthrough bleeds while taking HEMLIBRA may be at risk of serious side effects related to blood clots. -- These serious side effects include: • Thrombotic microangiopathy (TMA), a condition involving blood clots and injury to small blood vessels that may cause harm to your kidneys, brain, and other organs • Blood clots (thrombotic events), which may form in blood vessels in your arm, leg, lung, or head -- Carefully follow your healthcare provider’s instructions regarding when to use an on-demand bypassing agent or factor VIII, and the dose and schedule to use for breakthrough bleed treatment. If aPCC (Feiba®) is needed, talk to your healthcare provider in case you feel you need more than 100 U/kg of aPCC (Feiba®) total. -- Your body may make antibodies against HEMLIBRA, which may stop HEMLIBRA from working properly. Contact your healthcare provider immediately if you notice that HEMLIBRA has stopped working for you (eg, increase in bleeds). -- The most common side effects of HEMLIBRA include: injection site reactions (redness, tenderness, warmth, or itching at the site of injection), headache, and joint pain. These are not all of the possible side effects of HEMLIBRA. You can speak with your healthcare provider for more information.
we don't talk anymore
we don't talk anymore
Doctor mommy Episode 8. #africanstorytelling #storytelling #africanstory #africanstorytime #storytime
Doctor mommy Episode 8. #africanstorytelling #storytelling #africanstory #africanstorytime #storytime

About

Legal